Literature DB >> 12426049

GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats.

Mónica Diez-Ariza1, Mónica García-Alloza, Berta Lasheras, Joaquín Del Río, María Javier Ramírez.   

Abstract

ACh release from the rat frontal cortex was increased by both local, 0.1-1 microM, and systemic, 0.1-10 microg/kg, administration of the 5-HT(3) receptor antagonist ondansetron, reaching a maximum peak of 143% over basal values. Bicuculline, 1-10 microM, and flumazenil, 5-10 mg/kg, antagonists at different sites of the GABA(A) receptor, also enhanced ACh release, with maximum effects of 85 and 124% above baseline, respectively. GABA(A) receptor antagonists potentiated the effect induced by ondansetron on ACh release, reaching a peak increase of 238% (with bicuculline) and 259% (with flumazenil) over basal levels. These results suggest an interaction of ondansetron with GABAergic neurons modulating ACh release in the rat frontal cortex in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426049     DOI: 10.1016/s0006-8993(02)03483-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans.

Authors:  V Di Lazzaro; A Oliviero; E Saturno; M Dileone; F Pilato; R Nardone; F Ranieri; G Musumeci; T Fiorilla; P Tonali
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

Review 2.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

3.  Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease.

Authors:  R Nardone; A Bratti; F Tezzon
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

4.  Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL.

Authors:  Raffaele Nardone; Yvonne Höller; Aljosha Thomschewski; Alexander Baden Kunz; Piergiorgio Lochner; Stefan Golaszewski; Eugen Trinka; Francesco Brigo
Journal:  J Neural Transm (Vienna)       Date:  2014-03-28       Impact factor: 3.575

5.  The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release.

Authors:  Mei Huang; Anna R Felix; Sunoh Kwon; David Lowe; Tanya Wallace; Luca Santarelli; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2013-12-07       Impact factor: 4.530

6.  Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice.

Authors:  Nicola Kuczewski; Eugenio Aztiria; Dinesh Gautam; Jürgen Wess; Luciano Domenici
Journal:  J Physiol       Date:  2005-05-26       Impact factor: 5.182

7.  Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease.

Authors:  Nitish Kamble; Amitabh Bhattacharya; Shantala Hegde; N Vidya; Mohit Gothwal; Ravi Yadav; Pramod Kumar Pal
Journal:  Behav Brain Res       Date:  2022-01-05       Impact factor: 3.352

8.  The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.

Authors:  Mei Huang; Anna R Felix; Dorothy G Flood; Chaya Bhuvaneswaran; Dana Hilt; Gerhard Koenig; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

9.  Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.

Authors:  M Diez-Ariza; C Redondo; M García-Alloza; B Lasheras; J Del Río; M J Ramírez
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

10.  Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.

Authors:  Juan Jose Ramos-Rodriguez; Sara Molina-Gil; Raquel Rey-Brea; Esther Berrocoso; Monica Garcia-Alloza
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.